Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03182816 | CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Shanghai Cell Therapy Research InstituteOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT03179007 | CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 40 | Shanghai Cell Therapy Research InstituteOTHER | 1 | Jun 7, 2017 | clinicaltrials |
| NCT00983359 | Stereotactic Radiation Therapy in Treating Patients With Brain Metastases | completed | N/A | 40 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT03171220 | Neoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid Tumors(NRT-01) | unknown | Phase 1 / Phase 2 | 40 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jun 6, 2017 | clinicaltrials |
| NCT01910545 | Phase 1 Study of OTS167 in Patients With Solid Tumors | completed | Phase 1 | 32 | OncoTherapy Science, Inc.INDUSTRY | 1 | Jun 1, 2017 | clinicaltrials |
| NCT02086721 | Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor(L19-IL2) | completed | Phase 1 | 18 | Maastricht Radiation OncologyOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00728429 | Aerobic Exercise in Patients Receiving Chemotherapy for Cancer | terminated | N/A | 1 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00112593 | Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer | completed | N/A | 5 | Fred Hutchinson Cancer CenterOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT01415297 | Dose Escalation Study of NKP-1339 to Treat Advanced Solid Tumors | completed | Phase 1 | 46 | Niiki Pharma Inc.INDUSTRY | 1 | May 19, 2017 | clinicaltrials |
| NCT01893879 | Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema(PCTTPL) | terminated | N/A | 14 | Stanford UniversityOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT00459238 | Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants | completed | N/A | 104 | Georgetown UniversityOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT00674193 | Evaluating Dactinomycin and Vincristine in Young Patients With Cancer | completed | — | 158 | Children's Oncology GroupNETWORK | 3 | May 17, 2017 | clinicaltrials |
| NCT00954642 | A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 24 | Genentech, Inc.INDUSTRY | 0 | May 17, 2017 | clinicaltrials |
| NCT02490475 | A Multiple-Dose Study of RhuMab 2C4 and Docetaxel in the Treatment of Advanced Solid Tumors | completed | Phase 1 | 19 | Hoffmann-La RocheINDUSTRY | 2 | May 17, 2017 | clinicaltrials |
| NCT02766842 | Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) | withdrawn | Phase 2 | 0 | Johns Hopkins UniversityOTHER | 1 | May 15, 2017 | clinicaltrials |
| NCT00217724 | Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer | terminated | N/A | 18 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00258440 | Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer | terminated | N/A | 7 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00335478 | Daptomycin in Treating Neutropenia and Fever in Patients With Cancer | completed | Phase 2 | 54 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00972686 | Dose-Escalation Study of GSK2126458(FTIH) | completed | Phase 1 | 79 | GlaxoSmithKlineINDUSTRY | 2 | May 9, 2017 | clinicaltrials |
| NCT01031953 | Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy | terminated | Phase 1 / Phase 2 | 34 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00408499 | Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 64 | University of California, DavisOTHER | 1 | May 8, 2017 | clinicaltrials |
| NCT01453387 | MSC2015103B in Solid Tumors | terminated | Phase 1 | 28 | EMD SeronoINDUSTRY | 1 | May 8, 2017 | clinicaltrials |
| NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | completed | Phase 1 | 74 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 4, 2017 | clinicaltrials |
| NCT02735798 | 64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets | withdrawn | Early Phase 1 | 0 | Pamela MunsterOTHER | 0 | May 4, 2017 | clinicaltrials |
| NCT01129349 | Phase 1 Study of Oprozomib Administered Orally in Patients With Advanced Refractory or Recurrent Solid Tumors | completed | Phase 1 | 44 | AmgenINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT01577745 | A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors | completed | Phase 1 | 58 | MedImmune LLCINDUSTRY | 1 | May 2, 2017 | clinicaltrials |
| NCT01949545 | Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment | completed | Phase 1 | 46 | AmgenINDUSTRY | 4 | May 2, 2017 | clinicaltrials |
| NCT02274610 | Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer(DOPNP201) | completed | Phase 1 | 18 | Samyang Biopharmaceuticals CorporationINDUSTRY | 0 | May 1, 2017 | clinicaltrials |
| NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | completed | Phase 2 | 12 | St. Jude Children's Research HospitalOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT00186979 | Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors | completed | Phase 1 | 34 | St. Jude Children's Research HospitalOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT00489411 | Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer | completed | Phase 3 | 231 | Alliance for Clinical Trials in OncologyOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT01571024 | BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer | completed | Phase 1 | 17 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT00937417 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Apr 24, 2017 | clinicaltrials |
| NCT02567396 | Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 24, 2017 | clinicaltrials |
| NCT03117101 | Study of the AL3810 in the Treatment of Advanced Solid Tumor | completed | Phase 1 | 17 | Haihe Biopharma Co., Ltd.INDUSTRY | 1 | Apr 17, 2017 | clinicaltrials |
| NCT01359696 | A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma | completed | Phase 1 | 40 | Genentech, Inc.INDUSTRY | 2 | Apr 12, 2017 | clinicaltrials |
| NCT01940133 | A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309 | completed | Phase 1 | 28 | PIQUR Therapeutics AGINDUSTRY | 1 | Apr 12, 2017 | clinicaltrials |
| NCT00182754 | Octreotide in Treating Patients With Cancer-Related Malignant Ascites | completed | Phase 3 | 33 | Alliance for Clinical Trials in OncologyOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT01957995 | Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | University of Southern CaliforniaOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT01240590 | A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC) | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2017 | clinicaltrials |
| NCT02040558 | Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors | terminated | Phase 1 | 44 | MallinckrodtINDUSTRY | 1 | Apr 5, 2017 | clinicaltrials |
| NCT00217490 | Individual Counseling and/or Computer-Based Counseling in Helping Healthy Women Adopt a Cancer Prevention Diet | completed | N/A | 621 | Kaiser PermanenteOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00519662 | Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors | completed | Phase 1 | 32 | Sunesis PharmaceuticalsINDUSTRY | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00956813 | Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy | completed | Phase 3 | 210 | Alliance for Clinical Trials in OncologyOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT01098643 | Satisfaction With Placement of Implantable Venous Access Devices in Patients With Solid Tumors | terminated | N/A | 88 | Vanderbilt UniversityOTHER | 1 | Apr 4, 2017 | clinicaltrials |
| NCT00731276 | Irinotecan in Treating Asian Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Centre, SingaporeOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT01297452 | BKM120 + Carboplatin + Paclitaxel for Patients With Advanced Solid Tumors | completed | Phase 1 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 31, 2017 | clinicaltrials |
| NCT00952848 | Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy | completed | Phase 2 | 18 | Virginia Commonwealth UniversityOTHER | 0 | Mar 29, 2017 | clinicaltrials |
| NCT01248949 | A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors | completed | Phase 1 | 162 | MedImmune LLCINDUSTRY | 1 | Mar 29, 2017 | clinicaltrials |
Data updated 24 days agoSource updated Jun 9, 2017source: clinicaltrials